← Open Payments lookup

JENNIFER FLANNERY: Open Payments

NPI 1790040640 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,343 in 108 payments from 15 companies in 2025. Trend: 2023 $676 · 2024 $1,893 · 2025 $2,343

Food & beverage: $2,343
CompanyPaymentsAmount
ABBVIE INC.32$582
Salix Pharmaceuticals, a division of Bausch Health US, LLC24$472
Ardelyx, Inc.17$323
GENZYME CORPORATION9$309
Celltrion USA Inc.4$168
Lilly USA, LLC2$125
Regeneron Healthcare Solutions, Inc.6$105
Aimmune Therapeutics, Inc.3$53
Takeda Pharmaceuticals U.S.A., Inc.3$51
PFIZER INC.3$45

Products named: XIFAXAN, DUPIXENT, IBSRELA, RINVOQ, ZYMFENTRA, ZEPBOUND, SKYRIZI, ZENPEP.

Industry payments across PA — which companies pay providers there.